SEC filing details

Form

Filing Date

11.06.2024

Document Date

11.06.2024

Form Description

An amendment to a SC 13D filing

Filing Group

Other

Company

BridgeBio Pharma

Issuer

BRIDGEBIO PHARMA, INC.

View HTML

Print Page

Email Alerts

RSS Feeds

Contact IR

join our investor mailing list

Stay informed on everything that is happening at BridgeBio Investor Relations.

Required fields denoted by an asterisk ().

3160 Porter Drive, Suite 250, Palo Alto, CA, 94304 | 650-391-9740 | info@bridgebio.com | MAT-AS—0001